image
Technology - Software - Application - NASDAQ - US
$ 3.01
4.96 %
$ 337 M
Market Cap
-7.05
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one WALD stock under the worst case scenario is HIDDEN Compared to the current market price of 3.01 USD, Waldencast plc is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one WALD stock under the base case scenario is HIDDEN Compared to the current market price of 3.01 USD, Waldencast plc is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one WALD stock under the best case scenario is HIDDEN Compared to the current market price of 3.01 USD, Waldencast plc is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart WALD

image
$4.2$4.2$4.0$4.0$3.8$3.8$3.6$3.6$3.4$3.4$3.2$3.2$3.0$3.0$2.8$2.8$2.6$2.6$2.4$2.4$2.2$2.2Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
274 M REVENUE
25.55%
-58.6 M OPERATING INCOME
28.50%
-48.6 M NET INCOME
45.94%
-8.82 M OPERATING CASH FLOW
70.38%
-2.92 M INVESTING CASH FLOW
-46.44%
5.58 M FINANCING CASH FLOW
-87.41%
63.3 M REVENUE
-7.32%
44.6 M OPERATING INCOME
-10.08%
-5.04 M NET INCOME
-0.00%
-5.69 M OPERATING CASH FLOW
-0.00%
-698 K INVESTING CASH FLOW
-0.00%
5.66 M FINANCING CASH FLOW
0.00%
Balance Sheet Waldencast plc
image
Current Assets 104 M
Cash & Short-Term Investments 14.8 M
Receivables 26.3 M
Other Current Assets 62.5 M
Non-Current Assets 872 M
Long-Term Investments 0
PP&E 15.7 M
Other Non-Current Assets 857 M
6.41 %87.78 %Total Assets$975.9m
Current Liabilities 76.9 M
Accounts Payable 25.1 M
Short-Term Debt 32.2 M
Other Current Liabilities 19.6 M
Non-Current Liabilities 169 M
Long-Term Debt 150 M
Other Non-Current Liabilities 19.2 M
10.20 %13.11 %7.95 %60.94 %7.80 %Total Liabilities$245.9m
EFFICIENCY
Earnings Waterfall Waldencast plc
image
Revenue 274 M
Cost Of Revenue 82.1 M
Gross Profit 192 M
Operating Expenses 250 M
Operating Income -58.6 M
Other Expenses -9.94 M
Net Income -48.6 M
300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)274m(82m)192m(250m)(59m)10m(49m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
70.01% GROSS MARGIN
70.01%
-21.39% OPERATING MARGIN
-21.39%
-15.50% NET MARGIN
-15.50%
-6.41% ROE
-6.41%
-4.35% ROA
-4.35%
-6.31% ROIC
-6.31%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Waldencast plc
image
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)(90m)(90m)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Net Income -48.6 M
Depreciation & Amortization 60 M
Capital Expenditures -3.01 M
Stock-Based Compensation 9.39 M
Change in Working Capital -6.76 M
Others -25.1 M
Free Cash Flow -11.8 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Waldencast plc
image
Wall Street analysts predict an average 1-year price target for WALD of $6.33 , with forecasts ranging from a low of $5 to a high of $7.5 .
WALD Lowest Price Target Wall Street Target
5 USD 66.11%
WALD Average Price Target Wall Street Target
6.33 USD 110.41%
WALD Highest Price Target Wall Street Target
7.5 USD 149.17%
Price
Max Price Target
Min Price Target
Average Price Target
88776655443322Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Waldencast plc
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion globenewswire.com - 1 week ago
Waldencast plc (WALD) Q4 2024 Earnings Call Transcript Waldencast plc (NASDAQ:WALD ) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Ashley Helgans - Jefferies Linda Bolton Weiser - D.A. Davidson Olivia Tong - Raymond James Operator Greetings, welcome to the Waldencast Fourth Quarter and Fiscal Year 2024 Earnings Call. seekingalpha.com - 1 month ago
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 globenewswire.com - 1 month ago
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. globenewswire.com - 1 month ago
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion globenewswire.com - 2 months ago
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. globenewswire.com - 3 months ago
Waldencast Announces Participation in the 2025 IMCAS World Congress LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the 2025 International Master Course on Aging Science (IMCAS) World Congress, which will be held in Paris from January 30, 2025 to February 1, 2025. globenewswire.com - 3 months ago
Milk Makeup to Launch at Ulta Beauty This Spring The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ: WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nationwide and on Ulta.com. prnewswire.com - 3 months ago
Waldencast Announces Participation in the ICR Conference 2025 WHITE PLAINS, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in investor meetings and host a presentation at the ICR Conference 2025 being held at The Grande Lakes Orlando in Orlando, Florida on January 13, 2025. globenewswire.com - 3 months ago
Waldencast plc. (WALD) Q3 2024 Earnings Call Transcript Waldencast plc. (NASDAQ:WALD ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Dana Telsey - Telsey Advisory Group Sydney Wagner - Jefferies Susan Anderson - Canaccord Genuity Linda Bolton Weiser - D.A. seekingalpha.com - 5 months ago
Waldencast Reports Q3 2024 Financial Results $70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 globenewswire.com - 5 months ago
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. globenewswire.com - 5 months ago
8. Profile Summary

Waldencast plc WALD

image
COUNTRY US
INDUSTRY Software - Application
MARKET CAP $ 337 M
Dividend Yield 0.00%
Description Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Contact 10 Bank Street, White Plains, NY, 10606 http://www.waldencast.com
IPO Date May 12, 2021
Employees 335
Officers Mr. Manuel Manfredi Chief Financial Officer Ms. Hind Sebti Co-Founder, Chief Growth Officer & Director Mr. Michel Brousset Founder, Chief Executive Officer & Director Ms. Elisabeth Milan General Counsel